SWA
OSTX

Stratos Wealth Advisors’s OS Therapies Inc OSTX Stock Holding History

Stratos Wealth Advisors’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.5K Hold
13,817
– – ﹤0.01% 608
2025
Q4 		$19.3K Buy
+13,817
New +$24.9K ﹤0.01% 653

Other funds holding OSTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stratos Wealth Advisors's OSTX Position: Q1 2026 in Review

Stratos Wealth Advisors held its OS Therapies Inc (OSTX) position steady in Q1 2026 at 13,817 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Stratos Wealth Advisors first reported a position in OSTX in Q4 2025 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • Stratos Wealth Advisors held 13,817 shares of OS Therapies Inc worth $19.5K as of Q1 2026.
  • Stratos Wealth Advisors left its OS Therapies Inc share count unchanged in Q1 2026.
  • OS Therapies Inc made up ﹤0.01% of Stratos Wealth Advisors's portfolio in Q1 2026, its #608 holding.
  • Stratos Wealth Advisors first reported a position in OS Therapies Inc in Q4 2025 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.